Our research findings may offer novel perspectives on the function of the ZNF468‐AURKA axis in ESCC and identify potential therapeutic targets within the PI3K/AKT pathway, offering a promising avenue for developing targeted therapies to combat this aggressive cancer. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.